4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-12-001823
CHIEF EXECUTIVE OFFICER acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2012-12-06 | Grant or award | +100,000 | $0.50 | $50,000 | 252,174 | I |
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2012-12-06 | Grant or award · Warrant | +50,000 | 50,000 | I | ||
Loading xslF345X03/form4-12062012_091249.xml…